Cargando…
IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism
Interleukin (IL)-19, a member of the IL-10 family, is an anti-inflammatory cytokine produced primarily by macrophages. Nonalcoholic steatohepatitis (NASH) is a disease that has progressed from nonalcoholic fatty liver disease (NAFLD) and is characterized by inflammation and fibrosis. We evaluated th...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699936/ https://www.ncbi.nlm.nih.gov/pubmed/34944021 http://dx.doi.org/10.3390/cells10123513 |
_version_ | 1784620634701037568 |
---|---|
author | Azuma, Yasu-Taka Fujita, Takashi Izawa, Takeshi Hirota, Kana Nishiyama, Kazuhiro Ikegami, Airi Aoyama, Tomoko Ike, Mikihito Ushikai, Yumi Kuwamura, Mitsuru Fujii, Hideki Tsuneyama, Koichi |
author_facet | Azuma, Yasu-Taka Fujita, Takashi Izawa, Takeshi Hirota, Kana Nishiyama, Kazuhiro Ikegami, Airi Aoyama, Tomoko Ike, Mikihito Ushikai, Yumi Kuwamura, Mitsuru Fujii, Hideki Tsuneyama, Koichi |
author_sort | Azuma, Yasu-Taka |
collection | PubMed |
description | Interleukin (IL)-19, a member of the IL-10 family, is an anti-inflammatory cytokine produced primarily by macrophages. Nonalcoholic steatohepatitis (NASH) is a disease that has progressed from nonalcoholic fatty liver disease (NAFLD) and is characterized by inflammation and fibrosis. We evaluated the functions of IL-19 in a NAFLD/NASH mouse model using a 60% high fat diet with 0.1% methionine, without choline, and with 2% cholesterol (CDAHFD). Wild-type (WT) and IL-19 gene-deficient (KO) mice were fed a CDAHFD or standard diet for 9 weeks. Liver injury, inflammation, and fibrosis induced by CDAHFD were significantly worse in IL-19 KO mice than in WT mice. IL-6, TNF-α, and TGF-β were significantly higher in IL-19 KO mice than in WT mice. As a mechanism using an in vitro experiment, palmitate-induced triglyceride and cholesterol contents were decreased by the addition of IL-19 in HepG2 cells. Furthermore, addition of IL-19 decreased the expression of fatty acid synthesis-related enzymes and increased ATP content in HepG2 cells. The action of IL-19 in vitro suppressed lipid metabolism. In conclusion, IL-19 may play an important role in the development of steatosis and fibrosis by directly regulating liver metabolism and may be a potential target for the treatment of liver diseases. |
format | Online Article Text |
id | pubmed-8699936 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86999362021-12-24 IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism Azuma, Yasu-Taka Fujita, Takashi Izawa, Takeshi Hirota, Kana Nishiyama, Kazuhiro Ikegami, Airi Aoyama, Tomoko Ike, Mikihito Ushikai, Yumi Kuwamura, Mitsuru Fujii, Hideki Tsuneyama, Koichi Cells Article Interleukin (IL)-19, a member of the IL-10 family, is an anti-inflammatory cytokine produced primarily by macrophages. Nonalcoholic steatohepatitis (NASH) is a disease that has progressed from nonalcoholic fatty liver disease (NAFLD) and is characterized by inflammation and fibrosis. We evaluated the functions of IL-19 in a NAFLD/NASH mouse model using a 60% high fat diet with 0.1% methionine, without choline, and with 2% cholesterol (CDAHFD). Wild-type (WT) and IL-19 gene-deficient (KO) mice were fed a CDAHFD or standard diet for 9 weeks. Liver injury, inflammation, and fibrosis induced by CDAHFD were significantly worse in IL-19 KO mice than in WT mice. IL-6, TNF-α, and TGF-β were significantly higher in IL-19 KO mice than in WT mice. As a mechanism using an in vitro experiment, palmitate-induced triglyceride and cholesterol contents were decreased by the addition of IL-19 in HepG2 cells. Furthermore, addition of IL-19 decreased the expression of fatty acid synthesis-related enzymes and increased ATP content in HepG2 cells. The action of IL-19 in vitro suppressed lipid metabolism. In conclusion, IL-19 may play an important role in the development of steatosis and fibrosis by directly regulating liver metabolism and may be a potential target for the treatment of liver diseases. MDPI 2021-12-13 /pmc/articles/PMC8699936/ /pubmed/34944021 http://dx.doi.org/10.3390/cells10123513 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Azuma, Yasu-Taka Fujita, Takashi Izawa, Takeshi Hirota, Kana Nishiyama, Kazuhiro Ikegami, Airi Aoyama, Tomoko Ike, Mikihito Ushikai, Yumi Kuwamura, Mitsuru Fujii, Hideki Tsuneyama, Koichi IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism |
title | IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism |
title_full | IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism |
title_fullStr | IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism |
title_full_unstemmed | IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism |
title_short | IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism |
title_sort | il-19 contributes to the development of nonalcoholic steatohepatitis by altering lipid metabolism |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699936/ https://www.ncbi.nlm.nih.gov/pubmed/34944021 http://dx.doi.org/10.3390/cells10123513 |
work_keys_str_mv | AT azumayasutaka il19contributestothedevelopmentofnonalcoholicsteatohepatitisbyalteringlipidmetabolism AT fujitatakashi il19contributestothedevelopmentofnonalcoholicsteatohepatitisbyalteringlipidmetabolism AT izawatakeshi il19contributestothedevelopmentofnonalcoholicsteatohepatitisbyalteringlipidmetabolism AT hirotakana il19contributestothedevelopmentofnonalcoholicsteatohepatitisbyalteringlipidmetabolism AT nishiyamakazuhiro il19contributestothedevelopmentofnonalcoholicsteatohepatitisbyalteringlipidmetabolism AT ikegamiairi il19contributestothedevelopmentofnonalcoholicsteatohepatitisbyalteringlipidmetabolism AT aoyamatomoko il19contributestothedevelopmentofnonalcoholicsteatohepatitisbyalteringlipidmetabolism AT ikemikihito il19contributestothedevelopmentofnonalcoholicsteatohepatitisbyalteringlipidmetabolism AT ushikaiyumi il19contributestothedevelopmentofnonalcoholicsteatohepatitisbyalteringlipidmetabolism AT kuwamuramitsuru il19contributestothedevelopmentofnonalcoholicsteatohepatitisbyalteringlipidmetabolism AT fujiihideki il19contributestothedevelopmentofnonalcoholicsteatohepatitisbyalteringlipidmetabolism AT tsuneyamakoichi il19contributestothedevelopmentofnonalcoholicsteatohepatitisbyalteringlipidmetabolism |